Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jessica Russo"'
Publikováno v:
Cancer Biology & Therapy, Vol 24, Iss 1 (2023)
Birt–Hogg–Dubé syndrome (BHD) is an autosomal dominant disorder caused by germline mutations in the folliculin gene (FLCN) that result in the functional loss of the tumor suppressor folliculin. It is classically associated with cutaneous hamarto
Externí odkaz:
https://doaj.org/article/dbd2b25e262f4e8aac7f01b0cb15ce92
Autor:
Jessica Russo, Veda N. Giri
Publikováno v:
Nature Reviews Urology. 19:331-343
Autor:
Scherr, Jessica Russo
Publikováno v:
IS: International School; Autumn2023, p22-26, 5p
Autor:
Raphael A. Malbrue, Lori Mattox, Stephen J. Kolb, Charlotte J. Sumner, Jessica Russo, Kelly A. Rich, Megan G. Pino, Patrick L. Heilman, Christopher G. Wier, Lingling Kong, Elizabeth Keckley, Anthony B. Reynolds, Amy Knapp, Catalin S. Buhimschi
Publikováno v:
Gene Ther
Numerous pediatric neurogenetic diseases may be optimally treated by in utero gene therapy (IUGT); but advancing such treatments requires animal models that recapitulate developmental physiology relevant to humans. One disease that could benefit from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b849da8aafad37f4d434196f7e736d
https://europepmc.org/articles/PMC10216882/
https://europepmc.org/articles/PMC10216882/
Autor:
Mark Mann, Leonard G. Gomella, William Kevin Kelly, Nicholas Bowler, Joseph K Izes, Thenappan Chandrasekar, Perry R. Weiner, Ayako Shimada, Veda N. Giri, Edouard J. Trabulsi, Anne Calvaresi, Patrick Mille, Miranda Tsang, James Ryan Mark, Jessica Russo, Donald Preate, Costas D. Lallas, Nathan Handley, Carey McDougall, Laura Gross, Colette Hyatt, Irvin H. Hirsch
Publikováno v:
JCO Precis Oncol
JCO precision oncology, vol 5, iss 5
JCO precision oncology, vol 5, iss 5
PURPOSE Germline testing (GT) for prostate cancer (PCA) is now central to treatment and hereditary cancer assessment. With rising demand for and shortage of genetic counseling (GC), tools to deliver pretest informed consent across practice settings a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29377e1dafb4a3762bfa25cb309061d8
https://europepmc.org/articles/PMC8462590/
https://europepmc.org/articles/PMC8462590/
Publikováno v:
The Urologic clinics of North America. 48(3)
Germline genetic testing is becoming more prevalent in urology clinics because of precision medicine for prostate cancer treatment. Genetic testing results can also influence cancer screening discussions for patients and/or their families. An importa
Publikováno v:
SSRN Electronic Journal.
This study proposes an approach to track unethically procured organs in particular in countries or regions where investigations cannot be performed by utilizing forensic DNA methodology. Using China as an example, previous research has concluded that
Autor:
Veda N. Giri, Laura Gross, Heather H. Cheng, Jessica Russo, Channing Judith Paller, Jennifer M Johnson, Emily Steinberger Weg, Stacy Loeb
Publikováno v:
Journal of Clinical Oncology. 40:184-184
184 Background: With the increasing indications for germline testing for prostate cancer (PCA), there is a growing need for a spectrum of providers to develop working knowledge and understand considerations of germline testing and genetic counseling.
Autor:
Veda N. Giri, Laura Gross, Jessica Russo, Ayako Shimada, Christopher McNair, William Kevin Kelly, Leonard G. Gomella
Publikováno v:
Journal of Clinical Oncology. 40:188-188
188 Background: Germline testing for prostate cancer (PCA) is now central to treatment, screening, and hereditary cancer management. The Fanconi anemia (FA) pathway is a key DNA repair pathway involved in PCA biology and treatment. Prevalence of FA g
Publikováno v:
The Canadian journal of urology. 26(5 Suppl 2)
Germline genetic testing for prostate cancer is helping to inform risk stratification and staging of prostate cancer and also screening for men with family history of prostate cancer. Genetic counseling is an important piece of germline genetic testi